{"id":"NCT01001377","sponsor":"Amgen","briefTitle":"ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer","officialTitle":"A Randomized, Multicenter, Open-label, Phase 3 Study to Compare the Efficacy and Safety of Panitumumab and Cetuximab in Subjects With Previously Treated, Wild-type KRAS, Metastatic Colorectal Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-02-02","primaryCompletion":"2013-02-05","completion":"2017-03-07","firstPosted":"2009-10-26","resultsPosted":"2014-03-24","lastUpdate":"2022-09-21"},"enrollment":1010,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Metastatic Colorectal Cancer"],"interventions":[{"type":"DRUG","name":"Cetuximab","otherNames":["Erbitux"]},{"type":"DRUG","name":"Panitumumab","otherNames":["Vectibix"]}],"arms":[{"label":"Cetuximab","type":"ACTIVE_COMPARATOR"},{"label":"Panitumumab","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to compare the effect of panitumumab versus cetuximab on overall survival (OS) for chemorefractory metastatic colorectal cancer (mCRC) among patients with wild-type Kirsten rat Sarcoma-2 virus (KRAS) tumors.","primaryOutcome":{"measure":"Overall Survival","timeFrame":"From randomization until the data cut-off date of 5 February 2013. Maximum time on study was 155 weeks.","effectByArm":[{"arm":"Cetuximab","deltaMin":10,"sd":null},{"arm":"Panitumumab","deltaMin":10.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":"0.0007"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":152,"countries":["United States","Australia","Belgium","Bulgaria","Canada","China","Czechia","France","Hong Kong","India","Israel","Italy","Latvia","Lithuania","Malaysia","Netherlands","Peru","Philippines","Poland","Romania","Russia","Serbia","Singapore","Slovakia","South Africa","South Korea","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["27716478","24739896","29898991","30487126","33026965","32605298","27085587"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":169,"n":503},"commonTop":["Rash","Dermatitis acneiform","Hypomagnesaemia","Diarrhoea","Pruritus"]}}